Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Neutral Tate & Lyle (TATE) by Goldman Sachs
- Hold Renishaw (RSW) by Deutsche Bank
- Buy Gooch & Housego (GHH) by Deutsche Bank
- Buy Oxford Nanopore Technologies (ONT) by Berenberg
- Sell Liontrust Asset Management (LIO) by Deutsche Bank
- Buy Flutter Entertainment (DI) (FLTR) by Deutsche Bank
- Buy Polar Capital Holdings (POLR) by Deutsche Bank
- Hold Pearson (PSON) by Deutsche Bank
- Hold Rathbones Group (RAT) by Deutsche Bank
- Buy Hikma Pharmaceuticals (HIK) by Deutsche Bank
- Buy Hays (HAS) by Deutsche Bank
- Buy WPP (WPP) by Deutsche Bank
- Neutral Shell (SHEL) by Citi
- Buy BP (BP.) by Citi
- Underweight GSK (GSK) by Morgan Stanley
- Underweight Rightmove (RMV) by Barclays
- Equal Weight International Consolidated Airlines Group SA (CDI) (IAG) by Barclays
- Buy Jadestone Energy (JSE) by Berenberg
- Underperform Ocado Group (OCDO) by RBC Capital
- Equal Weight Pearson (PSON) by Barclays
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,260 open tips for AstraZeneca (AZN)
| Latest Bid : 15,502.00p | Latest Ask : 15,506.00p |
| High Today : 15,514.00p | Low Today : 15,172.00p |
| This Years High : 15,542.00p | This Years Low : 9,667.00p |
| Volume : 670,915 | MKT Cap : £240901M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | UBS | Premium Only | 2026-02-26 05:52:00 26/02/2026 | 2.63% |
| Buy | Berenberg | Premium Only | 2026-02-18 05:20:00 18/02/2026 | 0.28% |
| Add | Simon Watkins | Premium Only | 2026-02-17 08:35:00 17/02/2026 | 1.93% |
| Outperform | ODDO BHF | Premium Only | 2026-02-16 08:29:00 16/02/2026 | 3.85% |
| Hold | DZ Bank | Premium Only | 2026-02-12 13:37:00 12/02/2026 | 2.07% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 15,502.00p | Latest Ask : 15,506.00p |
| High Today : 15,514.00p | Low Today : 15,172.00p |
| This Years High : 15,542.00p | This Years Low : 9,667.00p |
| Volume : 670,915 | MKT Cap : £240901M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | UBS | Premium Only | 2026-02-26 05:52:00 26/02/2026 | 2.63% |
| Buy | Berenberg | Premium Only | 2026-02-18 05:20:00 18/02/2026 | 0.28% |
| Add | Simon Watkins | Premium Only | 2026-02-17 08:35:00 17/02/2026 | 1.93% |
| Outperform | ODDO BHF | Premium Only | 2026-02-16 08:29:00 16/02/2026 | 3.85% |
| Hold | DZ Bank | Premium Only | 2026-02-12 13:37:00 12/02/2026 | 2.07% |